Mr. Malvern Munjoma | Prophylaxis | Best Researcher Award

Posted on by Pencis

Mr. Malvern Munjoma | Prophylaxis | Best Researcher Award

Population Solutions for Health | Zimbabwe.

Author Profile

Scopus

Orcid

🎓EARLY ACADEMIC PURSUITS

From his formative years, Mr. Malvern Munjoma exhibited an exceptional passion for biomedical sciences and public health advocacy. He began his academic journey with a Bachelor’s degree in Biomedical Sciences, where he built a strong foundation in microbiology, immunology, and clinical diagnostics. He then advanced to specialize in infectious disease research, focusing on the mechanisms of disease transmission and preventive strategies—a pathway that would later define his impactful career in prophylactic medicine.

💼PROFESSIONAL ENDEAVORS

Throughout his professional career, Mr. Munjoma has served in public health institutions, research organizations, and clinical laboratories across Southern Africa. His roles have included infectious disease specialist, clinical research associate, and public health educator. His work consistently bridges the gap between clinical evidence and community-based healthcare, emphasizing disease prevention, early intervention, and health policy development.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON PROPHYLAXIS

Mr. Munjoma’s most notable contributions lie in the field of prophylaxis—the science of preventing disease before it occurs. His research spans:

  • Pre-exposure prophylaxis (PrEP) in HIV prevention

  • Tuberculosis prophylaxis in high-risk populations

  • Vaccination efficacy and hesitancy in underserved communities

  • Community-based prophylactic outreach models

His work has shaped regional health strategies and led to the implementation of low-cost preventive programs in rural settings. His voice is also central in promoting ethical and accessible preventive healthcare, especially among marginalized populations.

🌍IMPACT AND INFLUENCE

Mr. Munjoma’s influence extends beyond research. He is a trusted advisor to health ministries, a contributor to public health campaigns, and a mentor to young scientists. His projects have directly impacted disease control efforts across Sub-Saharan Africa, influencing vaccination coverage, HIV/AIDS reduction programs, and community prophylaxis awareness. His ability to combine rigorous science with grassroots impact defines his leadership in global health resilience.

🏆RESEARCH GRANTS AND FUNDING

Mr. Munjoma has successfully led and contributed to projects funded by:

  • The Global Fund to Fight AIDS, Tuberculosis and Malaria

  • USAID HIV and AIDS Programs

  • African Academy of Sciences (AAS) Research Fellowships

🦠LEGACY AND FUTURE CONTRIBUTIONS

As a forward-thinking researcher, Mr. Munjoma is committed to driving innovations in disease prediction, preventive genomics, and digital health tools for community-based surveillance. His mentorship of aspiring public health leaders ensures a legacy of scientific integrity and societal transformation. He is currently working on a region-wide prophylaxis integration model aimed at reducing disease burdens across Southern Africa by 2030.

🌟A VISIONARY IN INFECTIOUS DISEASES

Mr. Malvern Munjoma stands as a visionary in the field of infectious diseases, with a focus that is not only scientific but deeply humanitarian. His work embodies a mission to protect, educate, and empower—positioning him as one of the most respected voices in disease prevention and global health security.

📑NOTABLE PUBLICATIONS

Acceptability and feasibility of implementing thermal ablation as a preventive cervical cancer treatment and the comparison of treatment outcome with cryotherapy in Zimbabwe

Authors: Malvern Munjoma, Stephano Gudukeya, Jabulani Mavudze, Staci Leuschner, Noah Taruberekera

Publication Year: 2024

Journal: ecancermedicalscience

A mixed-method study of feasibility and acceptability of the Dapivirine vaginal ring among adolescent girls and young women (AGYW) in selected Zimbabwean districts

Authors: Noah Taruberekera, Tsitsi B. Masvawure, Malvern Munjoma, Owen Mugurungi, Getrude Ncube, Miriam Mutseta, Munyaradzi Dhodho, Hanul Choi, Jabulani Mavudze, Tafara Moga, et al.

Publication Year: 2025

Journal: PLOS Global Public Health

Prof. Zhongde Zhang | Infectious Diseases Prevention | Best Researcher Award

Posted on by Pencis

Prof. Zhongde Zhang | Infectious Diseases Prevention | Best Researcher Award

Guangzhou University of Chinese Medicine| China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Professor Zhongde Zhang embarked on his academic journey with a profound focus on Traditional Chinese Medicine (TCM). His foundational studies at prestigious institutions in China enabled him to master both the theoretical and practical aspects of TCM, paving the way for his expertise in addressing complex health challenges, particularly in infectious disease prevention.

💼PROFESSIONAL ENDEAVORS

As the President of Guangdong Provincial Hospital of Traditional Chinese Medicine and Vice-President of Guangzhou University of Traditional Chinese Medicine, Professor Zhang has played a pivotal role in advancing TCM’s integration into modern medical systems. His leadership has elevated both institutions into centers of excellence, emphasizing research, education, and patient-centered care.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES PREVENTION

Professor Zhang’s contributions to infectious diseases prevention are revolutionary. His research emphasizes the synergistic potential of TCM and modern medicine in addressing respiratory diseases and other intractable illnesses. His groundbreaking approaches include developing TCM-based immune therapies, advancing the understanding of pathogenesis, and creating integrative treatment protocols.

🌍IMPACT AND INFLUENCE

Professor Zhang’s influence transcends national boundaries. His advocacy for the integration of Traditional and Modern Medicine in global health policies has positioned him as a global health advocate. His efforts in addressing antibiotic resistance, pandemics, and chronic respiratory diseases have significantly improved public health outcomes and reinforced TCM’s role in international health systems.

📚ACADEMIC CITES

With a prolific record of peer-reviewed publications, Professor Zhang’s research is widely recognized and frequently cited in international journals. His work has provided a robust evidence base for TCM applications in infectious disease prevention and treatment, further bridging the gap between Eastern and Western medicine.

🏆RESEARCH GRANTS AND FUNDING

Professor Zhang has successfully led projects under the Ministry of Science and Technology’s major research and development program and secured multiple National Natural Science Foundation grants. These prestigious grants have fueled innovative studies on infectious diseases, respiratory illnesses, and immune system modulation, strengthening his position as a leading researcher in TCM.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Professor Zhang’s legacy lies in his vision for the future of healthcare, where TCM seamlessly integrates with modern medical advancements. His commitment to mentorship, innovative research, and developing global collaborations ensures a lasting impact on medical science and infectious disease prevention.

🌟A VISIONARY IN INFECTIOUS DISEASES

Recognized as a National Famous TCM Scholar, Professor Zhang embodies the spirit of innovation and collaboration. His visionary leadership has redefined the role of TCM in preventing and managing infectious diseases, marking him as a trailblazer in this field.

📑NOTABLE PUBLICATIONS 

“Fuzheng Jiedu decoction alleviates H1N1 virus-induced acute lung injury in mice by suppressing the NLRP3 inflammasome activation”

Authors: Li, Y., Zou, H., Ma, L., …, Li, G., Zhang, Z.
Publication Year: 2025
Journal: Journal of Ethnopharmacology

” Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization”

Authors: Liao, R., Sun, Z.-C., Wang, L., …, Wu, J., Zhang, Z.
Publication Year: 2025
Journal: Bioactive Materials

“Efficacy and safety of integrated traditional Chinese and Western medicine for rheumatoid arthritis-interstitial lung disease: A systematic review and meta-analysis”

Authors: Lu, P., Li, L., Liu, B., …, Zhang, Z., Lu, C.
Publication Year: 2024
Journal: Heliyon

“Natural pachypodol integrated, lung targeted and inhaled lipid nanomedicine ameliorates acute lung injury via anti-inflammation and repairing lung barrier”

Authors: Sun, Z.-C., Liao, R., Xian, C., …, Liu, Y., Wu, J.
Publication Year: 2024
Journal: Journal of Controlled Release

“Mendelian randomization and Bayesian model averaging of autoimmune diseases and Long COVID”

Authors: Feng, J., Chen, J., Li, X., …, Lu, Y., Liu, Y.
Publication Year: 2024
Journal: Frontiers in Genetics

Prof Dr. Damalie Nakanjako | Immunology of Infections | Women Researcher Award

Posted on by Pencis

Prof Dr. Damalie Nakanjako | Immunology of Infections | Women Researcher Award

Prof Dr. Damalie Nakanjako, Makerere University, Uganda.

Prof. Dr. Damalie Nakanjako is a distinguished researcher in Immunology of Infections and a dedicated advocate for advancing women’s contributions to science. As a Professor of Medicine and a renowned immunologist, her research focuses on understanding immune responses to infectious diseases, particularly in resource-limited settings. She has made significant strides in studying HIV, tuberculosis, and other infections, contributing to innovative treatments and influencing global health policies. With numerous publications in high-impact journals, Prof. Nakanjako is internationally recognized for her leadership in research, clinical practice, and mentoring young scientists. Her groundbreaking contributions have positioned her as a leading voice in combating infections and improving health outcomes for vulnerable populations, while championing gender equity in research and academia.

Professional Profiles

Scopus Profile

Orcid  Profile

📚Education

Dr. Damalie Nakanjako’s education is marked by advanced training in medicine, biomedical sciences, and leadership. She earned her MBChB in Medicine and Surgery from Makerere University, Uganda in 1999, followed by a Master of Medicine (MMED) in Internal Medicine in 2005. She completed her PhD in Biomedical Sciences at the University of Antwerp, Belgium in 2010. In addition to her degrees, she has specialized in leadership and governance, earning a Certificate in Corporate Governance and a Certificate in Audit and Risk Management from the Institute of Corporate Governance of Uganda in 2022 and 2023. Dr. Nakanjako also holds a Certificate in Leadership and Management in Health from the University of Washington, USA (2015). She has participated in key workshops, such as the Functional Genomics and Systems Biology Workshop at the Uganda Virus Research Institute (2014), and a Post-Doctoral Fellowship there from 2012 to 2013. Her commitment to professional development includes clinical research training through the Infectious Diseases Institute and GloCal Health Institute.

💼Experience

Dr. Nakanjako has over 10 years of leadership experience in academia, serving as the Principal of Makerere University College of Health Sciences and Former Dean of the School of Medicine. She has also led collaborative research and training programs aimed at building Africa’s scientific capacity in Infection and Immunity.

 

🔬Research Focus

Dr. Nakanjako is a renowned researcher in Infection and Immunity, with extensive expertise in HIV care, treatment, and prevention in sub-Saharan Africa. Her research focuses on chronic HIV-associated inflammation, immune aging, and non-AIDS illnesses, as well as the use of mobile health (m-health) platforms for patient follow-up. She has published over 107 scientific papers and authored books such as Efficient HIV/AIDS Care in Resource-Limited Settings.

 

👩‍🏫Mentorship and Networking

A mentor to over 58 graduate students and post-doctoral researchers, Dr. Nakanjako is actively involved in programs like the Makerere University-Uganda Virus Research Institute Infection and Immunity (MUII) and the Afya Bora Consortium. She is also the director of the ADAPT One Health network, working on antimicrobial stewardship in sub-Saharan Africa.

 

🏆Awards

Dr. Nakanjako has received several prestigious awards throughout her career, including the TWAS-Abdool Karim Award in Biological Sciences (2022), which recognizes outstanding contributions to the field of biological sciences. In 2013, she was honored with the Fourth Annual Merle A. Sande Health Leadership Award for her leadership in health sciences. Additionally, she earned the Young Investigator Award at the 18th Conference on Retroviruses and Opportunistic Infections (CROI) (2011), highlighting her early and impactful contributions to medical research.

📑Top Note Publications

Title: Incidence and predictors of virological failure among HIV infected children and adolescents receiving second-line antiretroviral therapy in Uganda, a retrospective study

Authors: Musiime-Mwase F, Nakanjako D, Kanywa JB, Sewankambo N, Elyanu P.
Publication Year: 2024
Citations: 0

Title: Barriers and facilitators of cervical cancer screening literacy among rural women with HIV attending rural public health facilities in East Central Uganda: a qualitative study using the integrated model of health literacy

Authors: Namutundu J, Kiguli J, Nakku-Joloba E, Nakanjako D, Nakalembe M.
Publication Year: 2024
Citations: 0

Title: The clinical utility of cystatin C based eGFR in assessing renal function among HIV/AIDS patients on ART at Mildmay Uganda

Authors: Wekiya E, Mujuzi GP, Nakiyingi J, Mutebi EI, Nakanjako D.
Publication Year: 2024
Citations: 0

Title: Chronic immune activation and accelerated immune aging among HIV-infected adults receiving suppressive antiretroviral therapy for at least 12 years in an African cohort

Authors: Nakanjako D, Nabatanzi R, Ssinabulya I, Banturaki G, Castelnuovo B.
Publication Year: 2024
Citations: 0

Title: Effectiveness of intensive adherence counselling in achieving an undetectable viral load among people on antiretroviral therapy with low-level viraemia in Uganda

Authors: Nanyeenya N, Nakanjako D, Makumbi F, Huzaifah M, Kiwanuka N.
Publication Year: 2024
Citations: 2